Portuguese 
English 
Spanish 
3 min of reading 
0 comments 
Study Reveals How The Enzyme N4BP2 Causes Chromotripsis, Generates DNA Instability, And Accelerates Genetic Mutation In Aggressive Cancer.
A recent study published in the journal Science revealed a crucial advance in understanding why some tumors evolve so quickly and resistently:
researchers identified the enzyme N4BP2 as a key player in the process of chromotripsis, an extreme event of DNA instability associated with aggressive cancer.
The discovery was made by scientists at the University of California, San Diego, who observed in real-time how this enzyme triggers a cascade of genetic mutations capable of accelerating tumor growth and hindering treatments, paving the way for new therapeutic strategies.
-
Researchers from Embrapa have discovered how to transform the saline water found in 140,000 wells in the Brazilian Semi-Arid region into a tool for producing food in an area where agriculture has always relied solely on rainfall.
-
China inaugurates a ghost factory that operates in the dark 24 hours a day without any human workers and produces 10 million smartphones a year using 97% of equipment developed by the company itself.
-
Scientists create a semiconductor that mimics the human brain using hydrogen and boost a new generation of smart chips with learning capabilities and the potential to revolutionize artificial intelligence applications.
-
Scientists discover that humanity has exchanged one environmental disaster for another: the same chemicals that saved the ozone layer are now contaminating rivers, aquifers, and human blood with an eternal pollutant that is impossible to remove.
What Is Chromotripsis And Why Is It Alarming To Science
Chromotripsis is a rare genetic phenomenon in healthy cells but alarmingly common in advanced tumors.
Unlike traditional mutations, which occur gradually over time, this process works like a genetic explosion.
In just a few moments, an entire chromosome shatters into dozens or even hundreds of pieces.
Subsequently, the cell attempts to “rejoin” this material chaotically, creating genetic shortcuts that favor uncontrolled cell proliferation.
As a result, DNA becomes profoundly unstable.
This DNA instability gives rise to more adaptable tumors that are resistant to drugs and have a higher capacity to spread throughout the body.
Who Triggers Extreme Genetic Mutation
Until now, scientists knew what happened during chromotripsis but not who initiated the process. This gap prompted the new investigation conducted in California.
The researchers analyzed all known human nucleases, enzymes responsible for cutting DNA within cancer cells.
Among dozens of candidates, only one displayed decisive behavior: the enzyme N4BP2.
It was the only one capable of invading so-called micronuclei, fragile structures formed when a chromosome becomes isolated during cell division.
Without proper protection, this DNA becomes an easy target.
How The Enzyme N4BP2 Triggers Aggressive Cancer
Within the micronuclei, the action of the enzyme N4BP2 is direct and devastating.
The study describes that it cuts DNA intensely, rapidly, and uncontrollably, creating the ideal conditions for chromotripsis.
The experiments were conclusive. When scientists removed N4BP2 from brain cancer cells, chromosomal fragmentation dropped drastically. On the other hand, when the enzyme was introduced into healthy cells, previously stable chromosomes began to break.
In other words, it’s not just a statistical association. N4BP2 acts as a direct cause of the extreme genetic mutation observed in highly aggressive tumors.
Connection Between Chromotripsis And Extrachromosomal DNA
In addition to chromosomal fragmentation, researchers identified another concerning effect.
Tumors with high levels of the enzyme N4BP2 also showed significant amounts of extrachromosomal DNA, known as ecDNA.
These small genetic rings float outside the chromosomes and carry genes that accelerate tumor growth and help cancer evade medications.
The study suggests that this ecDNA may be a direct byproduct of the chaos initiated by chromotripsis.
In practice, this creates a dangerous cycle: more DNA instability generates more tumor adaptation, making aggressive cancer even more difficult to treat.
What Changes In The Fight Against Cancer From This Discovery
The identification of the enzyme N4BP2 shifts the focus of the fight against advanced tumors.
Instead of acting only after mutations arise, science now aims at the exact moment when the genetic disaster begins.
Blocking the action of N4BP2 or the pathways that allow its entry into micronuclei does not mean an immediate cure.
However, it may slow tumor progression, reduce the adaptability of cancer cells, and increase the effectiveness of existing treatments.
This is a strategic shift: slowing down cancer may be crucial for saving lives.
A New Path For More Effective Therapies
Although still in the experimental phase, the discovery marks a milestone in understanding the mechanisms that make some tumors so lethal.
By clarifying how chromotripsis, genetic mutation, and DNA instability connect, the study opens doors for more precise therapies.
It is not the definitive cure yet. However, by identifying who “pulls the trigger,” science gains an unprecedented advantage in the race against aggressive cancer—an advantage that could transform the future of cancer treatment.
-
Uma pessoa reagiu a isso.